Patents by Inventor Eli Young

Eli Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lectin compositions and methods for modulating an immune response to an antigen
    Patent number: 7629440
    Abstract: The present invention relates to a fusion polypeptide comprising at least about 10 contiguous amino acid residues of an influenza virus hemagglutinin and at least about 5 contiguous amino acids of a naturally occurring GM-CSF molecule.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: December 8, 2009
    Assignee: Genitrix, LLC
    Inventors: Andrew Segal, Eli Young
  • Lectin compositions and methods for modulating an immune response to an antigen
    Publication number: 20040039156
    Abstract: The present invention relates to a fusion polypeptide comprising at least about 10 contiguous amino acid residues of an influenza virus hemagglutinin and at least about 5 contiguous amino acids of a naturally occurring GM-CSF molecule.
    Type: Application
    Filed: August 20, 2002
    Publication date: February 26, 2004
    Inventors: Andrew Segal, Eli Young
  • Recombinant FIV glycoprotein 160 and P24 gag protein
    Patent number: 6228608
    Abstract: Feline immunodeficiency virus antigens from gp160 envelope protein, gp120 envelope protein and p24 gag protein, useful for the diagnosis, treatment, and prevention of FIV. The invention may also be used to purify FIV.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: May 8, 2001
    Assignee: Aquila Biopharmaceuticals, Inc.
    Inventors: Eli Young, Deborah Davis, James Storey, Gerald Beltz